Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid Leukemia. a Study on Behalf of the Acute Leukemia Working Party of EBMT

Avichai Shimoni, MD, Myriam Labopin, Bipin N. Savani, MD, Rose-Marie Hamladji, Dietrich W. Beelen, Prof. Dr. MD, Ghulam J. Mufti, DM, FRCP, FRCPath, Gerard Socié, MD PhD, Jeremy Delage, MD, Didier Blaise, MD PhD, Patrice Chevallier, MD PhD, Noel Milpied, MD PhD, Eric Deconinck, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler

Blood (2016) 128 (22): 2280.

https://doi.org/10.1182/blood.V128.22.2280.2280

Published: 2016

Journal Articles

Towards the Potential Use of In Vitro Expanded Regulatory T-Cells (Tregs) in Aplastic Anemia (AA): Opportunities for Therapy

Benedetta Costantini, MD MPhil, Shahram Kordasti, MD PhD, Marc Martinez-Llordella, PhD, Giovanni Povoleri, MPhil, Judith C. W. Marsh, MD FRCP, FRCPath, Frederic Toulza, PhD, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2016) 128 (22): 2673.

https://doi.org/10.1182/blood.V128.22.2673.2673

Published: 2016

Journal Articles

Internal Tandem Duplication Mutation of FLT3 (FLT3/ITD) Significantly Increases Inter Chromosomal Homologous Recombination Providing a Direct Link Between Constitutive FLT3-ITD Activity and Propagation of Copy Neutral Loss of Heterozygosity (CN-LOH) in Acute Myeloid Leukaemia

Terry J Gaymes, DPhil, Azim M Mohamedali, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2014) 124 (21): 2185.

https://doi.org/10.1182/blood.V124.21.2185.2185

Published: 2014

Journal Articles

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Meng Wang, MD PhD, Wenjia Wang, PhD, Ayesha Abeywardane, MD, Malinthi Adikarama, MD, Donal McLornan, MD PhD FRCPath, Kavita Raj, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Stephen Devereux, MD PhD FRCPath, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MD FRCP, FRCPath, Victoria T Potter, MD FRCPA, FRACP, Aleksandar Mijovic

Blood (2014) 124 (21): 2512.

https://doi.org/10.1182/blood.V124.21.2512.2512

Published: 2014

Journal Articles

Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients

Blood (2014) 124 (21): 4601.

https://doi.org/10.1182/blood.V124.21.4601.4601

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT

Blood (2014) 124 (21): 2530.

https://doi.org/10.1182/blood.V124.21.2530.2530

Published: 2014

Journal Articles

High Resolution Mass Cytometry (CyTOF) in Aplastic Anaemia (AA) Can Identify an Aberrant Treg Subset with Pro-Inflammatory Properties, Predicting Poor Response to Immunosuppressive Therapy

Shahram Kordasti, MD PhD, Thomas Seidl, Richard J Ellis, PhD, Austin Kulasekararaj, Xingmin Feng, PhD, Danielle M. Townsley, MD MSc, Susanne Heck, PhD, Neal S. Young, MD, Judith C Marsh, MD, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2014) 124 (21): 1600.

https://doi.org/10.1182/blood.V124.21.1600.1600

Published: 2014

Journal Articles

Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT

Avichai Shimoni, MD, Arnon Nagler, MD, Simona Iacobelli, PhD, Anja van Biezen, Dietrich Beelen, Ghulam J. Mufti, DM, FRCP, FRCPath, Fabio Ciceri, MD, Lothar Kanz, MD, Liisa Volin, MD, Carlos Richard, MD, Didier Blaise, MD PhD, Arnold Ganser, Thomas Luft, MD PhD, Patrice Chevallier, MD PhD, Rainer Schwerdtfeger, Theo de Witte, MD, Marie Robin, MD PhD, Nicolaus Kröger, MD

Blood (2014) 124 (21): 1216.

https://doi.org/10.1182/blood.V124.21.1216.1216

Published: 2014

Journal Articles

Feasibility and Optimal Schedule Of Using Eculizumab In Patients With Hemolytic Paroxysmal Nocturnal Hemoglobinuria (hPNH) With Severe Aplastic Anemia (SAA) Prior To Haemopoietic Stem Cell Transplant (HSCT)

Austin G Kulasekararaj, Victoria T Potter, MBBS, FRCPA, FRACP, Shreyans A Gandhi, MBBS, MD, Nana benson-Quarm, Joanna Large, RN, BSc, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, DM, FRCP, FRCPath, Judith Marsh

Blood (2013) 122 (21): 2482.

https://doi.org/10.1182/blood.V122.21.2482.2482

Published: 2013

Journal Articles

Comprehensive Mutational Screening Of 5-Azacitidne Treated Myelodysplastic Syndrome (MDS) Patients Fails To Identify a Specific Mutational Profile Predicting Response To Therapy

Austin G. Kulasekararaj, Azim M Mohamedali, PhD, Alexander E Smith, PhD, Syed A Mian, Nazia Matto, Terry J Gaymes, DPhil, Nicholas Lea, PhD, Joop Gaken, PhD, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2013) 122 (21): 2792.

https://doi.org/10.1182/blood.V122.21.2792.2792

Published: 2013

Journal Articles

Somatic Mutations Implicated In Myeloid Malignancies Are Frequent In Idiopathic Aplastic Anaemia and Its Relevance To Disease Classification and Treatment- a Comprehensive Analysis Of 150 Patients

Jie Jiang, PhD, Austin G Kulasekararaj, Alexander E Smith, PhD, Azim M Mohamedali, PhD, Shreyans A Gandhi, MBBS, MD, Barbara Czepulkowski, BSc, Judith Marsh, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2013) 122 (21): 803.

https://doi.org/10.1182/blood.V122.21.803.803

Published: 2013

Journal Articles

Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS

Victoria T Potter, BSc, MBBS, Victoria J Tindell, MBChB, Rachel Kesse-Adu, MBBS, Janet Hayden, Patience Pasipanodya, Laura Reiff-Zall, Judith C. W. Marsh, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Aloysius Y Ho, ZiYi Lim, MD, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2010) 116 (21): 2375.

https://doi.org/10.1182/blood.V116.21.2375.2375

Published: 2010

Journal Articles

Serum Ferritin and Cardiac/Liver Magnetic Resonance Imaging In Evaluating Iron Overload for Patients with Bone Marrow Failure Conditions Undergoing Non-Myeloablative HSCT

Victoria J Tindell, MBChB, Victoria T Potter, BSc, MBBS, Rachel Kesse-Adu, MBBS, Laura Reiff-Zall, Aloysius Y Ho, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Judith C. W. Marsh, MD, ZiYi Lim, MD

Blood (2010) 116 (21): 1331.

https://doi.org/10.1182/blood.V116.21.1331.1331

Published: 2010

Journal Articles

Polycomb Complex Group Gene Mutations and Their Prognostic Relevance In 5-Azacitidine Treated Myelodysplastic Syndrome Patients

Blood (2010) 116 (21): 125.

https://doi.org/10.1182/blood.V116.21.125.125

Published: 2010

Journal Articles

Cytokine Profile of Patients with Invasive Apsergillosis- Preliminary Results.

M. Mansour Ceesay, MRCP, FRCPath, Shahram Kordasti, MD, PhD, Lisa Berry, Melvyn Smith, PhD, Jim Wade, FRCPath, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA

Blood (2010) 116 (21): 1500.

https://doi.org/10.1182/blood.V116.21.1500.1500

Published: 2010

Journal Articles

Apoptin Induced Tumour Specific Killing Via Protein Kinase C Isoforms: A Potential Therapeutic Strategy In Plasma Cell Dyscrasias

Jie Jiang, Daryl Cole, Sr., Nigel Westwood, Lee Macpherson, Farzin Farzaneh, Ghulam J. Mufti, DM, FRCP, FRCPath, Mahvash Tavassoli, Joop Gaken

Blood (2010) 116 (21): 5039.

https://doi.org/10.1182/blood.V116.21.5039.5039

Published: 2010

Journal Articles

A Functional Assay for MicroRNA Target Identification and Validation

Joop Gaken, Azim Mohamedali, PHD, Jie Jiang, Farooq Malik, Austin G Kulasekararaj, Farzin Farzaneh, DPhil, Mahvash Tavassoli, Ghulam J. Mufti, DM, FRCP, FRCPath

Blood (2010) 116 (21): 3874.

https://doi.org/10.1182/blood.V116.21.3874.3874

Published: 2010

Journal Articles

Low Level Residual Extravascular Haemolysis Is Commom Following Eculizumab Treatment In Paroxysmal Nocturnal Haemoglobinuria(PNH), but Does Not Affect Transfusion Requirement

Austin G Kulasekararaj, PhD, Dupe Odunsi, PhD, Pramila Krishnamurthy, PhD, Hayden Janet, PhD, Ibrahim Momoh, Ghulam J. Mufti, DM, FRCP, FRCPath, Judith C. W. Marsh, MD, Modupe Elebute, MBBS, MD, MRCP, FRCPath

Blood (2010) 116 (21): 4240.

https://doi.org/10.1182/blood.V116.21.4240.4240

Published: 2010

Journal Articles

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML).

Shreyans A Gandhi, MBBS, MD, DNB, MRCP, Victoria T Potter, BSc, MBBS, Victoria J. Tindell, MBChB, Rachel Kesse-Adu, MBBS, Laura Reiff-Zall, Michelle Kenyon, Judith C. W. Marsh, MD, Aloysius Y Ho, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, ZiYi Lim, MD

Blood (2010) 116 (21): 1304.

https://doi.org/10.1182/blood.V116.21.1304.1304

Published: 2010

Journal Articles

Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.

M. Mansour Ceesay, MRCP, FRCPath, Ouni Jaffer, Phillip FC Lung, Michael T Marrinan, Ranjit Deshpande, Nicola Mullholland, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, DM, FRCP, FRCPath, Sujal R Desai, MBBS, MD, FRCR

Blood (2010) 116 (21): 4551.

https://doi.org/10.1182/blood.V116.21.4551.4551

Published: 2010

NARROW

Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid Leukemia. a Study on Behalf of the Acute Leukemia Working Party of EBMT

Towards the Potential Use of In Vitro Expanded Regulatory T-Cells (Tregs) in Aplastic Anemia (AA): Opportunities for Therapy

Internal Tandem Duplication Mutation of FLT3 (FLT3/ITD) Significantly Increases Inter Chromosomal Homologous Recombination Providing a Direct Link Between Constitutive FLT3-ITD Activity and Propagation of Copy Neutral Loss of Heterozygosity (CN-LOH) in Acute Myeloid Leukaemia

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Identification of a Prognostic Gene Expression Signature for AZA Response in MDS and CMML Patients

Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT

High Resolution Mass Cytometry (CyTOF) in Aplastic Anaemia (AA) Can Identify an Aberrant Treg Subset with Pro-Inflammatory Properties, Predicting Poor Response to Immunosuppressive Therapy

Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT

Feasibility and Optimal Schedule Of Using Eculizumab In Patients With Hemolytic Paroxysmal Nocturnal Hemoglobinuria (hPNH) With Severe Aplastic Anemia (SAA) Prior To Haemopoietic Stem Cell Transplant (HSCT)

Comprehensive Mutational Screening Of 5-Azacitidne Treated Myelodysplastic Syndrome (MDS) Patients Fails To Identify a Specific Mutational Profile Predicting Response To Therapy

Somatic Mutations Implicated In Myeloid Malignancies Are Frequent In Idiopathic Aplastic Anaemia and Its Relevance To Disease Classification and Treatment- a Comprehensive Analysis Of 150 Patients

Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS

Serum Ferritin and Cardiac/Liver Magnetic Resonance Imaging In Evaluating Iron Overload for Patients with Bone Marrow Failure Conditions Undergoing Non-Myeloablative HSCT

Polycomb Complex Group Gene Mutations and Their Prognostic Relevance In 5-Azacitidine Treated Myelodysplastic Syndrome Patients

Cytokine Profile of Patients with Invasive Apsergillosis- Preliminary Results.

Apoptin Induced Tumour Specific Killing Via Protein Kinase C Isoforms: A Potential Therapeutic Strategy In Plasma Cell Dyscrasias

A Functional Assay for MicroRNA Target Identification and Validation

Low Level Residual Extravascular Haemolysis Is Commom Following Eculizumab Treatment In Paroxysmal Nocturnal Haemoglobinuria(PNH), but Does Not Affect Transfusion Requirement

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML).

Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only